In a follow-up study in patients with breast and lung cancer, no increase in activated caspase 3 following chemotherapy was observed, which was attributed to the relatively small increase in activated caspase 3/7 in response to chemotherapy [13]. This evidence concerns the gene CASP3 and lung carcinoma.